Trial · NCT07910747
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 23 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Changes in plasma taurine concentrations | Baseline (Week 0) and post-intervention (Week 12). | Changes in plasma taurine concentrations will be assessed before and after interventions using high-performance liquid chromatography (HPLC). Results will be expressed as µmol/L. |
| Secondary | Changes in dietary intake | Baseline (Week 0) and post-intervention (Week 12). | Changes in dietary intake, including total energy, macronutrients and micronutrients intake will be estimated before and after interventions using three-day dietary records collected on two non-consecutive weekdays and one weekend day. Participants will be instructed to record in detail all foods and beverages consumed at each meal over a 24-hour period. Energy intake will be expressed in kilocalories per day (kcal/day). Carbohydrates and lipid intake will be expressed as percentage of total energy intake (%). Protein will be expressed as grams per kilograms of body weight per day (g/kg/day). Micronutrients will be expressed in the appropriate units for each nutrient. All the estimates will be performed using NutrabemPro® software. |
| Secondary | Changes in Peripheral Blood Mononuclear Cell (PBMC) Subpopulations | Baseline (Week 0) and post-intervention (Week 12). | Changes in PBMC subpopulations will be assessed before and after the interventions using flow cytometry. The following cell populations will be analyzed: T lymphocytes (CD3+), CD4+ T lymphocytes (CD3+CD4+), CD8+ T lymphocytes (CD3+CD8+), B lymphocytes (CD19+), and classical (CD14++CD16-), intermediate (CD14++CD16+), and non-classical (CD14+CD16++) monocytes. Results will be expressed as the percentage of the corresponding parent cell population, according to the flow cytometry gating strategy. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07910747/registered?page=2